- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AtriCure Inc (ATRC)
Track today's live AtriCure (ATRC) share price, performance and key data on this page with our current NASDAQ:ATRC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the AtriCure share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ATRC share price, head to our technical summary section, which provides analysis on AtriCure share price buy/sell indicators using real-time data (or discuss the AtriCure (ATRC) stock price today with other investors in the AtriCure NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ATRC share price (ISIN: US04963C2098) to enhance your trading decisions with our free investment tools and resources.
What Is the AtriCure Inc Share Price Today?
The AtriCure share price today is 58.54.
What Is the Stock Symbol for AtriCure Inc
The stock symbol (or 'ticker') for AtriCure Inc is "ATRC."
What Stock Exchange Does AtriCure Inc Trade On?
AtriCure Inc is listed and trades on the NASDAQ stock exchange.
Is AtriCure Inc a Good Stock to Buy?
Determining whether AtriCure (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ATRC share price (ISIN: US04963C2098) to enhance your trading decisions with our free investment tools and resources.
What Is the AtriCure Inc Share Price Today?
The AtriCure share price today is 58.54.
What Is the Stock Symbol for AtriCure Inc
The stock symbol (or 'ticker') for AtriCure Inc is "ATRC."
What Stock Exchange Does AtriCure Inc Trade On?
AtriCure Inc is listed and trades on the NASDAQ stock exchange.
Is AtriCure Inc a Good Stock to Buy?
Determining whether AtriCure (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.26
61.11
52 wk Range
25.36
66.02
ATRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.2661.11
52 wk Range
25.3666.02
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATRC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
64.89
Upside
+10.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
AtriCure receives Investment Bank Analyst Rating Update- Investing.com
Pro
AtriCure receives Investment Bank Analyst Rating Update- Investing.com
Pro
AtriCure stock hits 52-week high at $63.00- Investing.com
- AtriCure stock hits 52-week high at $63.00
- Investing.com
AtriCure receives Investment Bank Analyst Rating Update- Investing.com
Pro
AtriCure receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 64.89
(+10.85% Upside)
AtriCure Inc Earnings Call Summary for Q3/2026
- AtriCure reported Q3 2026 EPS of $0.17, beating consensus loss estimate of $0.04, with revenue of $154.45M topping forecasts by $3.3M.
- U.S. revenue surged 17.1% to $128M, driving overall 15% growth; gross margin improved 180 bps to 77.3% year-over-year.
- Company raised FY 2026 revenue guidance to $606M-$610M, implying 13.4%-14.1% growth; adjusted EBITDA outlook increased to $91M-$94M.
- Shares fell 2% after-hours to $59.20 despite beat, as investors took profits near 52-week highs and digested Q4 margin pressure warnings.
- Management expects BoxX-NoAF trial enrollment completion by year-end with spring 2027 data readout; new 30mm AtriClip FLEX-Mini launches December 2026.
Last Updated: 03/11/2026, 22:24
Read Full TranscriptEarnings
Latest Release
03/11/2026
EPS / Forecast
0.17 / -0.04
Revenue / Forecast
154.45M / 151.15M
Compare ATRC to Peers and Sector
Metrics to compare | ATRC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATRCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 200.3x | −0.5x | −0.2x | |
PEG Ratio | 1.33 | 0.14 | 0.00 | |
Price/Book | 5.6x | 2.2x | 2.6x | |
Price / LTM Sales | 5.1x | 2.1x | 2.8x | |
Upside (Analyst Target) | 10.8% | 54.0% | 64.8% | |
Fair Value Upside | Unlock | 17.1% | 9.7% | Unlock |
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula’s to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AtriCure (NASDAQ: ATRC) Share Price Today?
The AtriCure stock price today is 58.54 USD.
What Stock Exchange Does AtriCure (ATRC) Trade On?
AtriCure is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for AtriCure?
The stock symbol (also called a 'ticker') for AtriCure is "ATRC."
What Is the Current AtriCure Market Capitalisation?
As of today, AtriCure (NASDAQ: ATRC) market cap is 2.98B USD.
What Is AtriCure's (ATRC) Earnings Per Share (TTM)?
The AtriCure EPS is currently 0.31 (Trailing Twelve Months).
When Is the Next AtriCure Earnings Date?
AtriCure's next earnings report will be released on 23/02/2027.
Is ATRC a Buy or Sell From a Technical Analyst Perspective?
Based on today's AtriCure moving averages and other technical indicators, the daily buy/sell signal for ATRC stock is Neutral.
How Many Times Has AtriCure Stock Split?
AtriCure has split 0 times. (See the ATRC stock split history page for full effective split date and price information.)
How Many Employees Does AtriCure Have?
AtriCure has 1350 employees, based on their latest Companies House report.
What is the current trading status of AtriCure (NASDAQ: ATRC)?
As of 08/11/2026, AtriCure (ATRC) is trading at a share price of 58.54 USD, with a previous close of 58.54 USD. The stock has fluctuated within a day range of 58.26 USD to 61.11 USD, while its 52-week range spans from 25.36 USD to 66.02 USD.
What Is AtriCure (ATRC) Price Target According to Analysts?
The average 12-month price target for AtriCure is 64.89 USD, with a high estimate of 70 USD and a low estimate of 50 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +10.85% Upside potential.
What Is the ATRC Premarket Price?
ATRC's last pre-market stock price is 60.02 USD. The pre-market share volume is 740.00, and the stock has decreased by -1.26, or -2.06%.
What Is the ATRC After Hours Price?
ATRC's last after hours stock price is 58.11 USD, the stock has decreased by -0.43, or -0.73%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.